Mason Morfit
Mason Morfit is the Co-CEO and Chief Investment Officer of ValueAct Capital, an activist fund that manages over $16 billion on behalf of some of the world;s largest institutional investors. Prior to joining ValueAct Capital at inception, Morfit worked in equity research for Credit Suisse First Boston’s healthcare group where he focused on the managed care industry. He has lectured on issues of corporate governance and executive compensation at Stanford Law School's Director’s College, the Graduate School of Business at Stanford University, and the Haas School of Business at the University of California, Berkeley.
Mason Morfit Professional Experience / Academic History
Professional Experience
-
Chief Executive Officer and Chief Investment Officer
-
President & Chief Investment Officer
-
Board of Directors
Academic History
-
B.A., Political Economy
Since joining ValueAct in 2001, he has held several roles within the firm and worked with various tech companies.
He played an important role in ValueAct's nearly decade long investment in Valeant that has produced $3.6 billion in profits, an internal rate of return of more than 40%.
He was the first of four ValueAct partners who have served on Valeant's board, helping to recruit Mike Pearson to the CEO position and designing Pearson's compensation plan.
MORE ABOUT MASON MORFIT
Morfit previously served on the boards of Microsoft Corporation; Advanced Medical Optics, Inc.; C.R. Bard, Inc.; Immucor, Inc.; MSD Performance, Inc.; Solexa, Inc.; and Valeant Pharmaceuticals International.
He worked in equity research for Credit Suisse First Boston’s healthcare group where he focused on the managed care industry.
He is married to Jordana Brewster, known for her role in the "Fast and Furious" franchise.
CURRENT AFFILIATIONS
Board of Director, Tipping Point Community
Advisory Board Member, Princeton University's School of Public and International Affairs
MEDIA & PUBLICATIONS
Morfit has been featured in Bloomberg, CNBC, Forbes, Financial Times, Barron's, Business Insider, The Wall Street Journal, and Yahoo! Finance.
He has also been featured or quoted in Institutional Investor and TechCrunch.